Journal article

Effect of convalescent plasma on organ support-free days in critically ill patients With COVID-19: a randomized clinical trial

Abstract:: Importance: The evidence for benefit of convalescent plasma for critically ill patients with COVID-19 is inconclusive.

Objective: To determine whether convalescent plasma would improve outcomes for critically ill adults with COVID-19.

Design, Setting, and Participants: The ongoing Randomized, Embedded, Multifactorial, Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP) enrolled and randomized 4763 adults wi...
Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Estcourt, L. J., Turgeon, A. F., McQuilten, Z. K., McVerry, B. J., Al-Beidh, F., Annane, D., Arabi, Y. M., Arnold, D. M., Beane, A., Bégin, P., van Bentum-Puijk, W., Berry, L. R., Bhimani, Z., Birchall, J. E., Bonten, M. J. M., Bradbury, C. A., Brunkhorst, F. M., Buxton, M., Callum, J. L., … Roberts, D. J. (2021). Effect of convalescent plasma on organ support-free days in critically ill patients With COVID-19: a randomized clinical trial. JAMA, 326(17), 1690–1702.

MLA Style

Estcourt, L. J., et al. “Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: a Randomized Clinical Trial.” JAMA, vol. 326, no. 17, American Medical Association, 2021, pp. 1690–702.

Chicago Style

Estcourt, LJ, AF Turgeon, ZK McQuilten, BJ McVerry, F Al-Beidh, D Annane, YM Arabi, et al. 2021. “Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: a Randomized Clinical Trial.” JAMA 326 (17): 1690–1702.
Share
Print

Access Document

Publisher copy:: 10.1001/jama.2021.18178

Authors

+ Estcourt, LJ More by this author

Institution:: University of Oxford
Division:: MSD
Department:: RDM
Role:: Author
ORCID:: 0000-0003-4309-9162

+ Turgeon, AF More by this author

Role:: Author

+ McQuilten, ZK More by this author

Role:: Author

+ McVerry, BJ More by this author

Role:: Author

+ Al-Beidh, F More by this author

Role:: Author

More authors...

Contributors

+ Writing Committee for the REMAP-CAP Investigators

Role:: Contributor

+ Wellcome Trust More from this funder

Publisher:: American Medical Association
Journal:: JAMA More from this journal
Volume:: 326
Issue:: 17
Pages:: 1690-1702
Publication date:: 2021-10-04
Acceptance date:: 2021-09-24
DOI:: 10.1001/jama.2021.18178
EISSN:: 1538-3598
ISSN:: 0098-7484
Pmid:: 34606578

Language:: English
Keywords:: Writing Committee for the REMAP-CAP Investigators

FFR

treatment failure

respiration, artificial

immunization, passive

adult

ABO Blood-Group System

male

female

critical illness

hospital mortality

COVID-19

middle aged

aged

logistic models

length of stay

vasoconstrictor agents
Pubs id:: 1199361
Local pid:: pubs:1199361
Deposit date:: 2021-12-08

Terms of use

Copyright holder:: American Medical Association.
Copyright date:: 2021
Rights statement:: © 2021 American Medical Association. All rights reserved.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP